Malka Frantzen

The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents.

Hans Mark, Hank H. Yang, Kimberly M. Parker et al. · PubMed · 2003 · 418 citations

Chemotherapeutic Agents, Tumor Biology, Hematological Malignancy +11

Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties

Matthew J. Price, Chung-Chuan Chou, Malka Frantzen et al. · International Journal of Cardiology · 2005 · 196 citations

Regenerative Medicine, Heart Failure, Cardiogenic Shock +11

BLADDER RECONSTITUTION WITH BONE MARROW DERIVED STEM CELLS SEEDED ON SMALL INTESTINAL SUBMUCOSA IMPROVES MORPHOLOGICAL AND MOLECULAR COMPOSITION

Steve Y. Chung, NIKOLA P. KRIVOROV, V. Rausei et al. · The Journal of Urology · 2005 · 129 citations

Intramyocardial Injection of Allogenic Bone Marrow-Derived Mesenchymal Stem Cells Without Immunosuppression Preserves Cardiac Function in a Porcine Model of Myocardial Infarction

Raj Makkar, Matthew J. Price, Michael Lill et al. · Journal of Cardiovascular Pharmacology and Therapeutics · 2005 · 113 citations

Identification of polymorphisms of the IκBα gene associated with an increased risk of multiple myeloma

Kimberly M. Parker, Hans Mark, Steven J. Manyak et al. · Cancer Genetics and Cytogenetics · 2002 · 35 citations

Hematological Malignancy, Medicine, Genetics +8